Active	Status	Sponsor type	Region	Phase	Filter
5 Active 8 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
MultiStem (invimestrocel) / Athersys, Healios
MASTERS-2, NCT03545607 / 2019-001680-69: MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study	Recruiting	3	300	US, RoW	MultiStem, Placebo	Athersys, Inc, Medpace, Inc.	Ischemic Stroke	09/22	06/23
NCT02961504: Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements	Completed	2/3	206	Japan	HLCM051, Placebo	Healios K.K.	Stroke, Acute	03/21	02/23
MaCoViA, NCT04367077: MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)	Recruiting	2/3	400	US	MultiStem, Placebo	Athersys, Inc	ARDS	01/23	12/23
ONE-BRIDGE, NCT03807804: Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome	Completed	2	35	Japan	HLCM051	Healios K.K.	Respiratory Distress Syndrome, Adult	12/21	12/21
NCT04533464: MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome	Recruiting	2	156	US	MultiStem, Placebo	Healios K.K., Memorial Hermann Hospital, United States Department of Defense	Trauma, Adult Stem Cells	12/25	12/25
ATHX-105 / Athersys
No trials found
5HT2c agonist program / Athersys
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
MultiStem (invimestrocel) / Athersys, Healios
MASTERS-2, NCT03545607 / 2019-001680-69: MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study	Recruiting	3	300	US, RoW	MultiStem, Placebo	Athersys, Inc, Medpace, Inc.	Ischemic Stroke	09/22	06/23
NCT02961504: Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements	Completed	2/3	206	Japan	HLCM051, Placebo	Healios K.K.	Stroke, Acute	03/21	02/23
MaCoViA, NCT04367077: MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)	Recruiting	2/3	400	US	MultiStem, Placebo	Athersys, Inc	ARDS	01/23	12/23
ONE-BRIDGE, NCT03807804: Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome	Completed	2	35	Japan	HLCM051	Healios K.K.	Respiratory Distress Syndrome, Adult	12/21	12/21
NCT04533464: MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome	Recruiting	2	156	US	MultiStem, Placebo	Healios K.K., Memorial Hermann Hospital, United States Department of Defense	Trauma, Adult Stem Cells	12/25	12/25
ATHX-105 / Athersys
No trials found
5HT2c agonist program / Athersys
No trials found